[30-503-pm] Pharmacotherapies (Cancer) 1

Sat. Mar 30, 2024 3:30 PM - 4:30 PM [Room 503] Conference Center 503 (5F)

Chair: Ryoichi Yano, Hiromasa Tsuyama

+Add all to schedule

3:30 PM - 3:42 PM

[30-503-pm01S] Development of a predictive model neutrophil count variability during treatment to optimize pemetrexed dosing

○Haruka Narise¹, Kazunori Morita², Keiichi Shigetome¹, Harumi Tanoue², Kentaro Oniki¹, Junji Saruwatari¹ (1. Grad.Sch.Pharm.Sci.,Kumamoto Univ., 2. Dept.Pharm.Saiseikai Kumamoto.Hosp.)

3:42 PM - 3:54 PM

[30-503-pm02S] Dual targeting of mTOR and p53 shows potent activity against aggressive Acute monocytic leukaemia

○Jingmei Li¹, Emi Sugimoto¹, Keita Yamamoto¹, Yutong Dai¹, Sung-Joon Park², Kenta Nakai², Toshio Kitamura^3,4, Susumu Goyama¹ (1. Grad. Sch. Frontier. Sci., Tokyo Univ., 2. IMSUT, 3. Grad. Sch. Pharm. Sci., Tokyo Univ., 4. FBRI)

3:54 PM - 4:06 PM

[30-503-pm03] Contrastive transcriptome analysis to discover protective drugs for anticancer drug-induced hand-foot syndrome

○Jun Utsumi^1,3, Hisanori Shimizu², Yayoi Kamata³, Mitsutoshi Tominaga³, Kenji Takamori^3,4 (1. TIR Research Consulting LLC, 2. Cancer Institute Hospital, 3. Juntendo Itch Research Center, 4. Juntendo Urayasu Hospital)

4:06 PM - 4:18 PM

[30-503-pm04S] Establishing novel EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma.

○Kou Yonemaru¹, Ayumi Kanemaru^1,2, Satoru Shinriki³, Hideyuki Saito^1,4, Hirofumi Jono^1,4 (1. Department of Clinical Pharmaceutical Sciences, Kumamoto University, 2. Clinical Research, Innovation and Education Center, Tohoku University, 3. Department of Molecular Laboratory Medicine, Faculty of Life Sciences, Kumamoto University, 4. Department of Pharmacy, Kumamoto University Hospital)

4:18 PM - 4:30 PM

[30-503-pm05] Development of paclitaxel nanosuspensions for inhalation based on bead milling methods

○Hiroko Otake¹, Wataru Fukumoto¹, Kotone Mukai¹, Noriaki Nagai¹ (1. Pharm., Kindai Univ.)

Session information